Titre : | A comparison of HCV antibody testing in drug-free and methadone maintenance treatment programs in the United States |
Titre traduit : | (Comparaison du dépistage de la contamination par le virus de l'hépatite C chez les usagers de drogue en traitement de maintenance par la méthadone et chez les usagers en traitement à visée d'abstinence) |
Auteurs : | S. M. STRAUSS ; J. M. ASTONE ; D. C. DES JARLAIS ; H. HAGAN |
Type de document : | Périodique |
Année de publication : | 2004 |
Format : | 227-236 / fig. ; tabl. |
Note générale : |
Drug and Alcohol Dependence, 2004, 73, (3), 227-236 |
Langues: | Anglais |
Discipline : | TRA (Traitement et prise en charge / Treatment and care) |
Mots-clés : |
Thésaurus mots-clés HEPATITE ; DEPISTAGE ; USAGER ; SEROPOSITIVITE ; COMPARAISON ; TRAITEMENT DE MAINTENANCE ; ABSTINENCEThésaurus géographique ETATS-UNIS |
Résumé : |
ENGLISH : Drug treatment programs are uniquely situated to screen patients for antibodies for hepatitis C virus (HCV), an infectious disease that has reached epidemic proportions among drug users. This paper compares the accessibility and patients' use of opportunities for HCV antibody testing in a large sample of methadone and drug-free treatment programs (N = 256) in the US, and reports programs' recent changes and future plans concerning it. Results indicate that almost all methadone and about two-thirds of drug-free programs in the sample provided HCV antibody screening to at least some patients in 2001. While about two-thirds of the methadone and close to one-third of the drug-free programs offered this service to all patients, these programs report that only about 3/5 of their patients actually provided specimens for testing for HCV antibodies. Some drug treatment programs were planning to increase the availability and accessibility of HCV antibody screening, but others were planning to cut back on these services, primarily due to limited resources. These results can inform policymakers who advocate for increased HCV antibody screening in drug treatment programs about the current level and future plans for implementing these services, illuminating where resources and motivational efforts need to be targeted. (Review's abstract.) |
Note de contenu : | fig. ; tabl. |
Domaine : | Drogues illicites / Illicit drugs |
Refs biblio. : | 45 |
Affiliation : |
Nat. Develop. Res. Inst., Inc. 71 West 23rd St., NY 10010 Etats-Unis. United States. |
Numéro Toxibase : | 804601 |
Centre Emetteur : | 08 CAS Strasbourg |
Exemplaires
Disponibilité |
---|
aucun exemplaire |
Accueil